Altman Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.92M | Buy |
|
|||||
|
2023
Q4 | $1.68M | Buy |
|
|||||
|
2023
Q3 | $1.24M | Buy |
|
|||||
|
2023
Q1 | $1.35M | Buy |
|
|||||
|
2022
Q4 | $1.38M | Sell |
|
|||||
|
2022
Q3 | $1.12M | Buy |
|
|||||
|
2022
Q2 | $1.2M | Buy |
|
|||||
|
2022
Q1 | $1.72M | Sell |
|
|||||
|
2021
Q4 | $2.35M | Buy |
|
|||||
|
2021
Q3 | $3.38M | Buy |
|
|||||
|
2021
Q2 | $2.78M | Buy |
|
|||||
|
2021
Q1 | $1.82M | Sell |
|
|||||
|
2020
Q4 | $1.97M | Buy |
|
|||||
|
2020
Q3 | $2.16M | Buy |
|
|||||
|
2020
Q2 | $2.08M | Buy |
|
|||||
|
2020
Q1 | $1.09M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $291 | Buy |
|